Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LB03002 Rollover Study in Adults with Growth Hormone Deficiency
NCT00596037Phase 3Completed
- Sponsor
- LG Chem
- Start
- Aug 2006
- Primary completion
- Sep 2008
- Modality
- rProtein (Recombinant Protein), Biologic
01
Overview
A Phase 3 trial of Eutropin Plus in growth hormone deficiency (GHD), sponsored by LG Chem. Started Aug 2006; status: completed.
02
Drugs
Eutropin Plus
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00596037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00596037.